Pulmonary complications of cystic fibrosis

Respiratory Care

Volumn 54, Issue 5, 2009, Pages 618-625

  Flume, Patrick A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cystic fibrosis; Hemoptysis; Pneumothorax; Respiratory complications; Respiratory failure

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CONJUGATED ESTROGEN; DESMOPRESSIN; DORNASE ALFA; STEROID; TOBRAMYCIN; TRANEXAMIC ACID; VASOPRESSIN;

ARTIFICIAL EMBOLISM; ARTIFICIAL VENTILATION; BRONCHIAL ARTERY; BRONCHOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; HEMOPTYSIS; LUNG FIBROSIS; LUNG RESECTION; LUNG VENTILATION; MORBIDITY; MORTALITY; PATHOGENESIS; PATIENT CARE; PLEURODESIS; PNEUMOTHORAX; RESPIRATORY FAILURE; RESPIRATORY THERAPIST; THORAX RADIOGRAPHY;

CYSTIC FIBROSIS; DISEASE PROGRESSION; HUMANS; INCIDENCE; RESPIRATORY TRACT DISEASES; RISK FACTORS;

EID: 66849106907     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: 10.4187/aarc0443     Document Type: Conference Paper

References (62)

1. Cystic Fibrosis Foundation Patient Registry 2006 Annual data report to the center directors. Bethesda, Maryland; 2007.
2. Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ 1995;310(6994):1571-1572.
3. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994;150(2):448-454. (Pubitemid 24252357)
4. Birrer P, McElvaney NG, Rüdeberg A, Sommer CW, Liechti-Gallanti S, Kraemer R, et al. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 1994;150(1):207-213. (Pubitemid 24209960)
5. Paxton DG, Scott EP. Pneumothorax: an unusual complication in fibrocystic disease. Am J Dis Child 1966;111(3):311-312.
6. Flume PA, Strange C, Ye X, Ebeling M, Hulsey T, Clark LL. Pneumothorax in cystic fibrosis. Chest 2005;128(2):720-728. (Pubitemid 41140502)
7. Flume PA. Pneumothorax in cystic fibrosis. Chest 2003;123(1):217-221. (Pubitemid 36126735)
8. Rich RH, Warwick WJ, Leonard AS. Open thoracotomy and pleural abrasion in the treatment of spontaneous pneumothorax in cystic fibrosis. J Pediatr Surg 1978;13(3):237-242. (Pubitemid 8345256)
9. Tomashefski JF Jr, Bruce M, Stern RC, Dearborn DG, Dahms B. Pulmonary air cysts in cystic fibrosis: relation of pathologic features to radiologic findings and history of pneumothorax. Hum Pathol 1985;16(3):253-261. (Pubitemid 15143673)
10. Smit HJM. Spontaneous pneumothorax: pathogenesis and treatment related aspects. Amsterdam, 1999.
11. Stowe SM, Boat TF, Mendelsohn H, Stern RC, Tucker AS, Doershuk CF, Matthews LW. Open thoracotomy for pneumothorax in cystic fibrosis. Am Rev Respir Dis 1975;111(5):611-617.
12. McLaughlin FJ, Matthews WJ, Streider DJ, Khaw KT, Schuster S, Shwachman H. Pneumothorax in cystic fibrosis: management and outcome. J Pediatr 1982;100(6):863-869.
13. Bense L, Eklund G, Wiman LG. Smoking and the increased risk of contracting spontaneous pneumothorax. Chest 1987;92(6):1009-1012. (Pubitemid 18026537)
14. Jansveld CA, Dijkman JH. Primary spontaneous pneumothorax and smoking. BMJ 1975;4(5996):559-560.
15. Britto MT, Garrett JM, Dugliss MA, Daeschner CW Jr, Johnson CA, Leigh MW, et al. Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter study. Pediatrics 1998;101(2):250-256. (Pubitemid 28076658)
16. Verma A, Clough D, McKenna D, Dodd M, Webb AK. Smoking and cystic fibrosis. J Royal Soc Med 2001;94(Suppl 40):29-34.
17. Nunley DR, Ohori P, Grgurich WF, Iacono AT, Williams PA, Keenan RJ, Dauber JH. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 1998;114(5):1321-1329. (Pubitemid 28527406)
18. Geller DE, Kaplowitz H, Light MJ, Colin AA. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis Chest 1999;116(3):639-646. (Pubitemid 29428478)
19. Knutsen AP, Hutcheson PS, Mueller KR, Slavin RG. Serum immunoglobulins E and G anti-Aspergillus fumigatus antibody in patients with cystic fibrosis who have allergic bronchopulmonary aspergillosis. J Lab Clin Med 1990;116(5):724-727. (Pubitemid 20378815)
20. Alothman GA, Alsaadi MM, Ho BL, Ho SL, Dupuis A, Corey M, Coates AL. Evaluation of bronchial constriction in children with cystic fibrosis after inhaling two different preparations of tobramycin. Chest 2002;122(2):930-934.
21. Boat TF, di Sant' Agnese PA, Warwick WJ, Handwerger SA. Pneumothorax in cystic fibrosis. JAMA 1969;209(10):1498-1504.
22. Lifschitz MI, Bowman FO Jr, Denning CR, Wylie RH. Pneumothorax as a complication of cystic fibrosis. Am J Dis Child 1968;116(6):633-640.
23. Schidlow DV, Taussig LM, Knowles MR. Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis. Pediatr Pulmonol 1993;15(3):187-198.
24. Zirbes JM, Milla CE. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol 2008;43(6):607-610.
25. Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ Jr, Willey-Courand DB, et al. Cystic Fibrosis Pulmonary Guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007;176(10):957-969. (Pubitemid 350127838)
26. Efrati O, Harash O, Rivlin J, Bibi H, Meir MZ, Blau H, et al. Hemoptysis in Israeli CF patients. Prevalence, treatment, and clinical characteristics J Cyst Fibr 2008;7(4):301-306.
27. Flume PA, Yankaskas JR, Ebeling M, Hulsey T, Clark LL. Massive hemoptysis in cystic fibrosis. Chest 2005;128(2):729-738. (Pubitemid 41140503)
28. Charan NB, Baile EM, Paré PD. Bronchial vascular congestion and angiogenesis. Eur Respir J 1997;10(5):1173-1180. (Pubitemid 27201827)
29. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001;164(10 Pt 2):S39-S45.
30. McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med 2000;161(6):1877-1880. (Pubitemid 30418123)
31. Boussaud V, Parrot A, Mayaud C, Wislez M, Antoine M, Picard C, et al. Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Intens Care Med 2003;29(10):1840-1843. (Pubitemid 37373837)
32. Jewkes J, Kay PH, Paneth M, Citron KM. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 1983;38(8):572-578.
33. Karas A, Hankins JR, Attar S, Miller JE, McLaughlin JS. Pulmonary aspergillosis: an analysis of 41 patients. Ann Thor Surg 1976;22(1):1-7.
34. Rafferty P, Biggs BA, Crompton GK, Grant IW. What happens to patients with pulmonary aspergilloma? Analysis of 23 cases Thorax 1983;38(8):579-583.
35. Kalva SP, Wicky S. Mediastinal bronchial artery aneurysms: endovascular therapy in two patients. Catheter Cardiovasc Interven 2006;68(6):858-861. (Pubitemid 44847089)
36. Parker CM, Nolan R, Lougheed MD. Catamenial hemoptysis and pneumothorax in a patient with cystic fibrosis. Can Respir J 2007;14(5):295-297. (Pubitemid 47527463)
37. Brinson GM, Noone PG, Mauro MA, Knowles MR, Yankaskas JR, Sandhu JS, Jaques PF. Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis. Am J Respir Crit Care Med 1998;157(6 Pt 1):1951-1958. (Pubitemid 28311285)
38. Yankaskas JR, Egan TM, Mauro MA. Major complications. In: Yankaskas JR, Knowles MR, editors. Cystic fibrosis in adults. Philadelphia: Lippincott-Raven Publishers; 1999: 175-193.
39. Ramsey BW, Astley SJ, Aitken ML, Burke W, Colin AA, Dorkin HL, et al. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis 1993;148(1):145-151. (Pubitemid 23187234)
40. Cantin AM. DNase I acutely increases cystic fibrosis sputum elastase activity and its potential to induce lung hemorrhage in mice. Am J Respir Crit Care Med 1998;157(2):464-469. (Pubitemid 28090536)
41. Vidal V, Therasse E, Berthiaume Y, Bommart S, Giroux MF, Oliva VL, et al. Bronchial artery embolization in adults with cystic fibrosis: impact on the clinical course and survival. J Vasc Interven Radiol 2006;17(6):953-958. (Pubitemid 44315470)
42. Barben JU, Ditchfield M, Carlin JB, Robertson CF, Robinson PJ, Olinsky A. Major haemoptysis in children with cystic fibrosis: a 20-year retrospective study. J Cyst Fibr 2003;2(3):105-111. (Pubitemid 37051545)
43. Popper J. The use of premarin IV in hemoptysis. Diseases of the Chest 1960;37:659-660.
44. Bilton D, Webb AK, Foster H, Mulvenna P, Dodd M. Life threatening haemoptysis in cystic fibrosis: an alternative therapeutic approach. Thorax 1990;45(12):975-976.
45. Chang AB, Ditchfield M, Robinson PJ, Robinson CF. Major hemoptysis in a child with cystic fibrosis from multiple aberrant bronchial arteries treated with tranexamic acid. Pediatr Pulmonol 1996;22(6):416-420. (Pubitemid 27024447)
46. Graff GR. Treatment of recurrent severe hemoptysis in cystic fibrosis with tranexamic acid. Respiration 2001;68(1):91-94. (Pubitemid 32172962)
47. Liou TG, Woo MS, Cahill BC. Lung transplantation for cystic fibrosis. Curr Opin Pulm Med 2006;12(6):459-463. (Pubitemid 44624608)
48. Dantzker DR, Patten GA, Bower JS. Gas exchange at rest and during exercise in adults with cystic fibrosis. Am Rev Respir Dis 1982;125(4):400-405.
49. Lagerstrand L, Hjelte L, Jorulf H. Pulmonary gas exchange in cystic fibrosis: basal status and the effect of i.v. antibiotics and inhaled amiloride. Eur Respir J 1999;14(3):686-692. (Pubitemid 29479737)
50. Coffey MJ, FitzGerald MX, McNicholas WT. Comparison of oxygen desaturation during sleep and exercise in patients with cystic fibrosis. Chest 1991;100(3):659-662.
51. Fraser KL, Tullis DE, Sasson Z, Hyland RH, Thornley KS, Hanly PJ. Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia. Chest 1999;115(5):1321-1328. (Pubitemid 29230641)
52. Holland AE, Wilson JW, Kotsimbos TC, Naughton MT. Metabolic alkalosis contributes to acute hypercapnic respiratory failure in adult cystic fibrosis. Chest 2003;124(2):490-493. (Pubitemid 37000124)
53. Dray X, Kanaan R, Bienvenu T, Desmazes-Dufeu N, Dusser D, Marteau P, Hubert D. Malnutrition in adults with cystic fibrosis. Eur J Clin Nutr 2005;59(1):152-154. (Pubitemid 40104092)
54. Ford D, Flume PA. Impact of lung transplantation on site of death in cystic fibrosis. J Cyst Fibr 2007;6(6):391-395. (Pubitemid 350028702)
55. Robinson WM, Ravilly S, Berde C, Wohl ME. End-of-life care in cystic fibrosis. Pediatrics 1997;100(2 Pt 1):205-209. (Pubitemid 27328197)
56. Young AC, Wilson JW, Kotsimbos TC, Naughton MT. Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis. Thorax 2008;63(1):72-77.
57. Serra A, Polese G, Braggion C, Rossi A. Non-invasive proportional assist and pressure support ventilation in patients with cystic fibrosis and chronic respiratory failure. Thorax 2002;57(1):50-54. (Pubitemid 34081544)
58. Holland AE, Denehy L, Ntoumenopoulos G, Naughton MT, Wilson JW. Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis. Thorax 2003;58(10):880-884. (Pubitemid 37239237)
59. Davis PB, di Sant'Agnese PA. Assisted ventilation for patients with cystic fibrosis. JAMA 1978;239(18):1851-1854. (Pubitemid 8322871)
60. Slieker MG, van Gestel JP, Heijerman HG, Tramper-Stranders GA, van Berkout FT, van der Ent CK, Jansen NJ. Outcome of assisted ventilation for acute respiratory failure in cystic fibrosis. Intens Care Med 2006;32(5):754-758.
61. Yankaskas JR, Mallory GB Jr. Lung transplantation in cystic fibrosis: consensus conference statement. Chest 1998;113(1):217-226. (Pubitemid 28044949)
62. Belkin RA, Henig NR, Singer LG, Chaparro C, Rubenstein RC, Xie SX, et al. Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2006;173(6):659-666. (Pubitemid 43363808)